Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T16:13:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, reflecting a minor site version update.
    Difference
    0.1%
    Check dated 2026-10-11T15:52:23.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.7.0 in place of v3.6.6, indicating an updated version tag for the study record.
    Difference
    0.1%
    Check dated 2026-09-20T19:27:57.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a small software revision. It does not change any study information or user-facing functionality beyond metadata.
    Difference
    0.1%
    Check dated 2026-08-30T17:20:47.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision changes from v3.6.4 to v3.6.5 are shown at the bottom of the page, signaling a platform release. The update appears to be a backend/administrative change rather than affecting study content or data.
    Difference
    0.1%
    Check dated 2026-08-09T11:07:06.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Adds the Contacts/Locations and Study Status sections to the version history, improving access to study contact details and the current trial status. Introduces revision v3.6.4 for version 50 on 2026-07-17 and removes the prior v3.6.3 revision on 2026-04-23.
    Difference
    0.3%
    Check dated 2026-07-25T23:48:30.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.